St. Jude Medical Announces TOCCASTAR Clinical Trial Meets Primary Safety and Efficacy Endpoints at Heart Rhythm 2014

[Business Wire] – St. Jude Medical, Inc. , a global medical device company, today announced results of the TOCCASTAR clinical trial at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions in San Francisco. more

View todays social media effects on STJ

View the latest stocks trending across Twitter. Click to view dashboard

See who St. is hiring next, click here to view